Skip to main content
VCbacked
Log inGet Started

Allinaire Therapeutics

Cleveland, United States

Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.

$700K raised
Apr 2026
Venture - Series Unknown
BiotechnologyHealth CareTherapeutics

Top Investors

BioCrossroadsIU VenturesBioMotiv

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Allinaire Therapeutics

How much funding has Allinaire Therapeutics raised?
Allinaire Therapeutics has raised $700K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in April 2026.
Who are Allinaire Therapeutics's investors?
Allinaire Therapeutics's investors include BioCrossroads, IU Ventures, BioMotiv.
Where is Allinaire Therapeutics headquartered?
Allinaire Therapeutics is headquartered in Cleveland, United States.
What does Allinaire Therapeutics do?
Allinaire Therapeutics aims to develop novel therapeutics for Chronic Obstructive Pulmonary Disease (COPD) and other pulmonary diseases.
What stage is Allinaire Therapeutics at?
Allinaire Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Allinaire Therapeutics — Funding & Investors." VCBacked, April 14, 2026, https://www.vcbacked.co/company/allinaire-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2026). Allinaire Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/allinaire-therapeutics
Wikipedia (cite web)
{{cite web |title=Allinaire Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/allinaire-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Allterum Therapeutics
Houston$1.0M
Renaissance BioScience
Vancouver$599K
AlpalifeBio
Woburn$9.8M
Rapport Therapeutics
Boston$250.0M
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K